Indication

Treatment of moderate to severe chronic hand eczema (CHE) in adults for whom topical corticosteroids (TCS) are inadequate or inappropriate.

Medicine details

Medicine name:
delgocitinib (Anzupgo)
SMC ID:
SMC2817
Pharmaceutical company
LEO Pharma
BNF chapter
Skin
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC